VEEVA SYSTEMS INC
NYSE: VEEV·Pleasanton, California·CIK 0001393052
- Price
- $299.28
- Base IV
- $70.90
Valuation snapshot
At $299.28, the price is above even our bull case of $114.40.
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $70.90
- 24% of the price · range $37.90–$114.40
- Price vs base case
- 322% above
- $299.28 against $70.90
- Base case · our researched forecast, 2026-10-29See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
Whisker on the base case runs bear $37.90 to bull $114.40. Values per share.
Price against each value
- Bear case
- $37.90
- Price 690% above
- No growth
- …
- —
- Base case
- $70.90
- Price 322% above
What does Veeva Systems do?
It brought in $3.5B of sales in the 12 months to Jul 2026.
- Industry
- Technology
- Based in
- Pleasanton, California
- Trades on
- NYSE as VEEV
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Jul 2026, about 29¢ was left as profit after every cost, interest and tax. The biggest cost is making what it sells, 25¢ of every dollar.
- Making what it sells25¢
- Research and development24¢
- Sales, marketing and admin21¢
- Tax9¢
- Left as profit29¢
- Interest and other income came back in+8¢
Who pays Veeva Systems, and for what?
Veeva sells cloud software, data and consulting services built for life sciences companies. Customers pay mainly recurring subscription fees to use its software and data, plus fees for implementation and other services.
Its customers are mainly pharmaceutical, biotechnology, medical device and diagnostics, contract research and contract sales companies, with some customers in consumer products.
Subscription revenue
Fees for access to Veeva's software and data solutions.
Veeva Vault CRM interfaceImage: Veeva Systems Professional services and other revenue
Fees primarily for implementation, configuration, managed services, speakers bureau logistics and business consulting.
Commercial Solutions
Commercial Cloud and Data Cloud products, including sales, marketing, medical affairs and data tools.
Veeva Vault CRM account activity interface · October 2026Image: Veeva Systems R&D and Quality Solutions
Development Cloud and Quality Cloud products for research, clinical, regulatory, safety, quality and manufacturing work.
Veeva eTMF clinical trial dashboardImage: Veeva Systems
Where its work physically happens, beyond headquarters:
- Boston engineering hub — Boston, United States. Veeva identifies this engineering hub as a center for developing clinical trial software.
- Europe headquarters — Barcelona, Spain. Veeva designates this office as its European headquarters, anchoring its operations in a major revenue region.
- Japan headquarters — Tokyo, Japan. Veeva designates this office as its Japan headquarters, making it a regional base for its life sciences business.
- China headquarters — Shanghai, China. Veeva designates this office as its China headquarters, making it a regional base for its life sciences business.
- Asia Pacific headquarters — Singapore, Singapore. Veeva designates this office as its Asia Pacific headquarters, anchoring its regional operations.
How is the business doing?
Sales grew from $1.5B in 2021 to $3.2B in 2026, about 17% a year.
Running the business leaves about 30¢ of each sales dollar as operating profit, up from 26¢ in 2021.
What does management say it's aiming for?
Veeva says its public benefit purpose is to help make the industries it serves more productive and create high-quality jobs in its communities.
“to provide products and services that are intended to help make the industries we serve more productive”
What management says it is working on now:
Grow research, development and quality products
Management says R&D and Quality Solutions are expected to become a larger share of subscription and total revenue, supported by expanding customer use and product investment.
Veeva Systems FY2026 Form 10-KMove CRM customers to Vault CRM
Veeva is migrating customers from its legacy CRM product to Vault CRM, which runs on Veeva's own platform; the legacy product is supported through 2029.
Veeva Systems FY2026 Form 10-KInvest in products and AI
Management says it is investing in product development, including new features and applications, and Veeva AI agents integrated into its applications.
Veeva Systems FY2026 Form 10-KExpand worldwide
The company identifies expanding its international operations and customer base as a key part of its growth strategy.
Veeva Systems FY2026 Form 10-K
What's changing right now?
Growth is holding steady. In Q2 2027 it sold 18% more than a year earlier. The year before, quarters averaged 16%.
Its operating margin is wider than a year ago: 30¢ per sales dollar, against 25¢.
Since Oct 2026 the share price has fallen 4%, from $310.34 to $299.28.
Coming up
December 31, 2029
Legacy Veeva CRM support ends
Veeva says it will support its legacy CRM product and certain related applications through December 31, 2029, making the customer transition to Vault CRM a key event to follow.
Veeva Systems FY2026 Form 10-KProgram term: two years from January 2026
Share repurchase authorization expires
The board authorized up to $2 billion in share repurchases in January 2026. The program lasts two years and may be suspended or ended at any time.
Veeva Systems FY2026 Form 10-K
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
CRM migration and competition
Veeva must move customers from its legacy CRM to Vault CRM while competing with Salesforce. Customers may switch providers, and migration problems could disrupt service or damage customer relationships.
From the company's own filingsWould hit how fast sales growVeeva Systems FY2026 Form 10-K
Data security and service reliability
A breach, outage or defect could expose sensitive customer data, interrupt customers' operations, lead to claims or penalties, and cause customers to reduce or stop using Veeva's products.
From the company's own filingsWould hit how fast sales growVeeva Systems FY2026 Form 10-K
Customer concentration
The ten largest customers accounted for 28% of revenue in each of the last three fiscal years. Losing a large customer or having it reduce subscriptions could slow growth or lower revenue.
From the company's own filingsWould hit how fast sales growVeeva Systems FY2026 Form 10-K
Dependence on life sciences
Nearly all revenue comes from life sciences customers. Changes to drug pricing, healthcare funding, regulation, industry financing or consolidation could reduce customers' budgets or demand for Veeva's products.
From the company's own filingsWould hit how fast sales growVeeva Systems FY2026 Form 10-K
Third-party infrastructure
Veeva depends on outside providers for computing infrastructure and other technology services. A provider slowdown, failure or disruption could affect product availability and create costs or liability.
From the company's own filingsWould hit how much of each sale it keepsVeeva Systems FY2026 Form 10-K
Privacy and regulatory changes
Changing privacy, security and life sciences rules may require added compliance spending, reduce demand for products, or expose the company to liabilities.
From the company's own filingsWould hit how much of each sale it keepsVeeva Systems FY2026 Form 10-K
Management says its forward guidance may prove incorrect and identifies customer decisions and competition as risks.
From our researchWould hit how fast sales growVeeva Q2 FY2027 results
Second-quarter research and development expense rose to $222.918 million from $192.677 million a year earlier.
From our researchWould hit how much of each sale it keepsVeeva Q2 FY2027 Form 10-Q
Is it a good business?
From 2017 to 2026 it earned between 10% and 19% on its shareholders' equity, a median of 14%.
Over 10 years its operating margin ranged from 18¢ to 29¢ per sales dollar, a median of 25¢. Gross margin ran from 67¢ to 76¢.
It bought back shares: the count fell 1.6% in a year, so each remaining share owns a slightly bigger slice.
What might it be worth?
Net debt is excluded: The reported balance sheet does not yet establish a complete debt figure. The per-share value may change when resolved. No earlier published debt figure is available.
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $299.28. Our put its value between $37.90 and $114.40, with $70.90 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $37.90
Despite recent sales growth and stronger profits, this case assumes customer projects slow and Veeva must spend more to keep growing.
Base case, $70.90
With sales recently growing at a mid-teen pace and profits improving, this case assumes Veeva meets its current outlook and then grows more slowly as it gets larger.
Bull case, $114.40
Following faster sales growth and stronger profits in the latest quarter, this case assumes new customer wins lift sales above Veeva's outlook and make the business more profitable.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects far more than we do.Price above value: 322%
For Veeva Systems to be worth today's $299.28, sales would need to grow about 49.8% a year. We assume 10.1%. Over the last 5 years, sales grew 15.8% a year.
Keep in mind: investors are likely paying for things this model leaves out, such as new businesses or many more years of fast growth.
Do you think sales can grow 49.8% a year?
Try your own numbersWe're moderately sure of this range: it scores 61 out of 100 on our checks. The weakest point is terminal-value dependency.
Test the assumptions
Our base value of $70.90 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average10.1%
- Operating margin30.0%
- Long-term growth rate2.5%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$70.90 -76.3%


